Glycopyrrolate and Rectal prolapse - a phase IV clinical study of FDA data

Summary:

Rectal prolapse is reported as a side effect among people who take Glycopyrrolate (glycopyrrolate), especially for people who are female, 60+ old, also take Hydroxyzine, and have Depression.

The phase IV clinical study analyzes which people have Rectal prolapse when taking Glycopyrrolate. It is created by eHealthMe based on reports of 5,510 people who have side effects when taking Glycopyrrolate from the FDA, and is updated regularly.

What is Glycopyrrolate?

Glycopyrrolate has active ingredients of glycopyrrolate. It is often used in hyperhidrosis. eHealthMe is studying from 5,599 Glycopyrrolate users. Check the latest studies of Glycopyrrolate.

What is Rectal prolapse?

Rectal prolapse (falling of rectum from normal place) is found to be associated with 306 drugs and 341 conditions by eHealthMe. Check the latest studies of Rectal prolapse.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

5,510 people reported to have side effects when taking Glycopyrrolate.
Among them, 16 people (0.29%) have Rectal prolapse.

Could Glycopyrrolate cause Rectal prolapse?

Among these 16 people:

What is the gender of people who have Rectal prolapse when taking Glycopyrrolate? *

female: 100 %
male: 0.0 %

What is the age of people who have Rectal prolapse when taking Glycopyrrolate? *

What are other drugs people take besides Glycopyrrolate? *

What are other side effects people have besides Rectal prolapse? *

Zollinger-Ellison Syndrome (increased production of the hormone gastrin from a small tumour of pancreas): 16 people, 100.00%
Gallstones (stone formation by bile component): 16 people, 100.00%
Osteoporosis (bones weak and more likely to break): 16 people, 100.00%
Osteomyelitis (infection of bone): 16 people, 100.00%
Oesophageal Stenosis (narrowing of oesophagus): 16 people, 100.00%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 16 people, 100.00%
Kidney Stones: 16 people, 100.00%
Injury: 16 people, 100.00%
Weight Decreased: 16 people, 100.00%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 16 people, 100.00%

What are the existing conditions these people have? *

Pain: 16 people, 100.00%
High Blood Pressure: 16 people, 100.00%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 16 people, 100.00%
Depression: 16 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Glycopyrrolate and have Rectal prolapse?

- Check whether Rectal prolapse is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glycopyrrolate:

Glycopyrrolate (5,599 reports)

Rectal prolapse treatments and more:

Rectal prolapse (1,711 reports)

Browse all side effects of Glycopyrrolate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rectal prolapse:

Rectal prolapse (306 drugs)

Browse all the conditions that are associated with Rectal prolapse:

Rectal prolapse (341 conditions)

Related publications that referenced our studies

D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .
D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on glycopyrrolate (the active ingredients of Glycopyrrolate) and Glycopyrrolate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.